secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0001104659-25-004107
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS Life Sciences amends severance agreements for two officers to 15 months base salary upon change of control
--------------------------------------------------------------------------------

- Board approved amendments to change-in-control severance agreements for SVP/Chief Development Officer Dragan Cicic and SVP/CFO John Burns.
- Amendments provide for severance of 15 months of then-current base salary upon termination in connection with a change of control.
- Original agreements were dated December 14, 2021; other provisions remain unchanged.
- Full text of amendments to be filed in next periodic report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465925004107/0001104659-25-004107-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465925004107/tm253479d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-004107

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer